• 2018-07
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • Etienne Grimaldi M C Formento J L Francoual M


    [81] Etienne-Grimaldi M-C, Formento J-L, Francoual M, Francois E, Formento P, Renee N, et al. K-Ras mutations and treatment outcome in colorectal cancer patients receiv-ing exclusive fluoropyrimidine therapy. Clin Cancer Res 2008 Aug;14(15):4830–5. [82] Santini D, Loupakis F, Vincenzi B, Floriani I, Stasi I, Canestrari E, et al. High concor-dance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist 2008 Dec;13(12):1270–5. [83] Artale S, Sartore-Bianchi A, Veronese SM, Gambi V, Sarnataro CS, Gambacorta M, et al. Mutations of KRAS and BRAF in primary and matched metastatic sites of co-lorectal cancer. J Clin Oncol 2008;26:4217–9 Official Journal of the American Soci-ety of Clinical Oncology. United States.
    [85] Weber J-C, Meyer N, Pencreach E, Schneider A, Guerin E, Neuville A, et al. Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes. Int J Cancer 2007 Feb;120(3):524–32. [86] Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, Domingo E, et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 2007 Jan;26(1):158–63.
    [87] Albanese I, Scibetta AG, Migliavacca M, Russo A, Bazan V, Tomasino RM, et al. Het-erogeneity within and between primary colorectal carcinomas and matched me-tastases as revealed by analysis of Ki-ras and p53 mutations. Biochem Biophys Res Commun 2004 Dec;325(3):784–91.
    [88] Zauber P, Sabbath-Solitare M, Marotta SP, Bishop DT. Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas. Mol Pathol 2003 Jun 17;56(3):137–40.
    [89] Tortola S, Steinert R, Hantschick M, Peinado MA, Gastinger I, Stosiek P, et al. Discor-dance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J Clin Oncol 2001 Jun;19(11):2837–43.
    [90] Al-Mulla F, Going JJ, Sowden ET, Winter A, Pickford IR, Birnie GD. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 1998 Jun;185
    [91] Suchy B, Zietz C, Rabes HM. K-ras point mutations in human colorectal carcinomas: relation to MitomycinC and metastasis. Int J Cancer 1992 Aug;52(1):30–3. [92] Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural his-tory of human colorectal cancer. Eur J Cancer 1992;28A(6–7):1115–20. [93] Oudejans JJ, Slebos RJ, Zoetmulder FA, Mooi WJ, Rodenhuis S. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 1991 Dec;49(6):875–9.
    [94] Atreya CE, Sangale Z, Xu N, Matli MR, Tikishvili E, Welbourn W, et al. PTEN expres-sion is consistent in colorectal cancer primaries and metastases and associates with patient survival. Cancer Med 2013 Aug;2(4):496–506. 
    [95] Yarom N, Marginean C, Moyana T, Gorn-Hondermann I, Birnboim HC, Marginean H, et al. EGFR expression variance in paired colorectal cancer primary and metasta-tic tumors. Cancer Biol Ther 2010 Sep;10(5):416–21.
    [96] Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. J Clin Oncol 2004 Dec;22(23):4772–8.
    [97] Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee E, et al. Comparison of the mismatch repair system between primary and metastatic colorectal cancers using immunohisto-chemistry. J Pathol Transl Med 2017 Mar;51(2):129–36.
    [98] Haraldsdottir S, Roth R, Pearlman R, Hampel H, Arnold CA, Frankel WL. Mismatch repair deficiency concordance between primary colorectal cancer and correspond-ing metastasis. Familial Cancer 2016;15(2):253–60. [99] Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, et al. The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases. Clin Epigenetics 2017 May 2;9:46. [100] Kleist B, Meurer T, Poetsch M. Mitochondrial DNA alteration in primary and meta-static colorectal cancer: different frequency and association with selected clinico-pathological and molecular markers. Tumour Biol 2017 Mar;39(3) 1010428317692246.
    [101] Neerincx M, Sie DLS, van de Wiel MA, van Grieken NCT, Burggraaf JD, Dekker H, et al. MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing. Oncogene 2015 Oct 5;4(10):e170.